Sio Capital Gains An Impressive 23.3% In 2018 As Biotech Shorts Pay Off: Here Are The Companies That They Are Betting Against – ValueWalk Premium

Sio Capital Gains An Impressive 23.3% In 2018 As Biotech Shorts Pay Off: Here Are The Companies That They Are Betting Against

Sio Capital Management, the healthcare-focused long/short equity hedge fund achieved an outstanding outperformance for its partners in 2018.

Q4 hedge fund letters, conference, scoops etc

According to a copy of the firm's full-year letter, which has been reviewed by ValueWalk, Sio returned 23.3% net in 2018. These returns compare with returns of -4.4% for the S&P 500 Total Return Index, 1.0% for the MSCI World Healthcare Index, and -10.4% for the MSCI World Index.
If you’re looking for value stocks, and exclusive access to value-focused hedge fund managers, check out ValueWalk’s exclusive value newsletter, Hidden Value Stocks. Use code 15percent10 at checkout. Offer valid for next 10 subscribers or March 31, 2019 whichever comes first!

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

0